Catalent and Cevec team-up to offer protein CDMO services
Catalent and Cevec Pharmaceuticals have joined forces to offer cell line development and manufacturing services to biotechs.
Catalent and Cevec Pharmaceuticals have joined forces to offer cell line development and manufacturing services to biotechs.
Brazilian drug regulator Anvisa has called for increased pharmacovigilance and more effective reporting of adverse reactions by authorities worldwide.
Chiromics is one of a number of contractors to have landed deals with Big Pharmas this month, signing drug discovery agreements with BM-S and GSK.
Domestic regulatory efforts to improve ingredient quality will increase costs but Indian industry will remain competitive, according to the Secretary of Commerce.
New Communist Party General Secretary Xi Jinping wants to improve medical care and says China needs to “learn more about the world.”
A European industry group says EU efforts to ensure the quality of API made by manufactureres outside the region are inadequate and that mandatory inspections of overseas plants are a must.